Page last updated: 2024-11-04

sulfamethoxazole and Churg-Strauss Syndrome

sulfamethoxazole has been researched along with Churg-Strauss Syndrome in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Churg-Strauss Syndrome: Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, L1
Yang, Y1
Huang, S1

Other Studies

1 other study available for sulfamethoxazole and Churg-Strauss Syndrome

ArticleYear
Disseminated Nocardia farcinica infection in a patient with EGPA receiving hormonotherapy.
    The Lancet. Infectious diseases, 2021, Volume: 21, Issue:1

    Topics: Anti-Infective Agents; China; Churg-Strauss Syndrome; Cilastatin; Humans; Imipenem; Linezolid; Male;

2021